DRUG MARKETING Off-label marketing: free speech or illegal promotion?

被引：1
|
作者：
Silverman, Ed [1 ]
机构：
[1] Pharmalot, Millburn, NJ USA
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2013年 / 346卷
关键词：
D O I：
10.1136/bmj.f320
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The next forum for unraveling FDA off-label marketing rules: State and federal legislatures
    Sinha, Michael S.
    Kesselheim, Aaron S.
    [J]. PLOS MEDICINE, 2018, 15 (05):
  • [32] Medicolegal Sidebar: Free Speech Rights Versus Off-Label Use
    Green, Stuart A.
    Bal, B. Sonny
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2023, 481 (07) : 1285 - 1287
  • [33] Promotion of Drugs for Off-label Uses The US Food and Drug Administration at a Crossroads
    Kim, Jeanie
    Kapczynski, Amy
    [J]. JAMA INTERNAL MEDICINE, 2017, 177 (02) : 157 - 158
  • [34] Origins of the Prohibition Against Off-Label Promotion
    Coleman, Terry S.
    [J]. FOOD AND DRUG LAW JOURNAL, 2014, 69 (02) : 161 - 236
  • [35] Promotion of off-label use not always a crime
    Thompson, Cheryl A.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (06) : 478 - +
  • [36] Regulating Off-Label Promotion - A Critical Test
    Robertson, Christopher
    Kesselheim, Aaron S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (24): : 2313 - 2315
  • [37] What Is "False or Misleading" Off-Label Promotion?
    Bi, Kathryn
    [J]. UNIVERSITY OF CHICAGO LAW REVIEW, 2015, 82 (02): : 975 - 1021
  • [38] Off-label promotion under scrutiny by DOJ
    Spivack, Peter S.
    [J]. GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2008, 28 (11): : 10 - 12
  • [39] Off-Label Promotion, On-Targets Sales
    Fugh-Berman, Adriane
    Melnick, Douglas
    [J]. PLOS MEDICINE, 2008, 5 (10): : 1432 - 1435
  • [40] Off-label Drug Use and Adverse Drug Events Turning up the Heat on Off-label Prescribing
    Good, Chester B.
    Gellad, Walid F.
    [J]. JAMA INTERNAL MEDICINE, 2016, 176 (01) : 63 - 64
12345